ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
3 |
07:48 |
07:48 |
ASX - By Stock
|
344
|
117K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
344
|
117K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
344
|
117K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
344
|
117K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
0 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
344
|
117K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
K1RevivalClinic
|
8.6K |
3.2M |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
K1RevivalClinic
|
8.6K |
3.2M |
10 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
10
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
344
|
117K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Emyria and Reach Wellness Launch
|
|
K1RevivalClinic
|
10 |
2.6K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
10
|
2.6K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Emyria and Reach Wellness Launch
|
|
K1RevivalClinic
|
10 |
2.6K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
10
|
2.6K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
K1RevivalClinic
|
12K |
4.5M |
6 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
12K
|
4.5M
|
6
|
|
ASX - By Stock
|
PMT |
Re:
Ann: PMT Announces C$109M Investment and MOU with Albemarle
|
|
K1RevivalClinic
|
89 |
41K |
12 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
89
|
41K
|
12
|
|
ASX - By Stock
|
PMT |
Re:
Ann: PMT Announces Largest Lithium Pegmatite Resource in Americas
|
|
K1RevivalClinic
|
187 |
72K |
8 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
187
|
72K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
K1RevivalClinic
|
25 |
7.8K |
2 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
25
|
7.8K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
K1RevivalClinic
|
344 |
117K |
2 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
344
|
117K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT Ad jingles & slogan ideas for Sofpironium Bromide?
|
|
K1RevivalClinic
|
34 |
11K |
2 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
34
|
11K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT Ad jingles & slogan ideas for Sofpironium Bromide?
|
|
K1RevivalClinic
|
34 |
11K |
3 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
34
|
11K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
|
|
K1RevivalClinic
|
28 |
9.0K |
13 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
28
|
9.0K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
K1RevivalClinic
|
8.6K |
3.2M |
5 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
8.6K
|
3.2M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Worst Case Consideration
|
|
K1RevivalClinic
|
30 |
9.8K |
0 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
30
|
9.8K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
K1RevivalClinic
|
125 |
32K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
125
|
32K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
|
|
K1RevivalClinic
|
21 |
5.9K |
0 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
21
|
5.9K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
K1RevivalClinic
|
125 |
32K |
1 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
125
|
32K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
|
|
K1RevivalClinic
|
21 |
5.9K |
1 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
21
|
5.9K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
K1RevivalClinic
|
125 |
32K |
1 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
125
|
32K
|
1
|
|